Suppr超能文献

产前给予素高捷疗对宫内生长受限大鼠胎儿肝糖原合成的影响。

The effect of antenatal administration of solcoseryl on hepatic glycogen synthesis in rat fetuses with intrauterine growth retardation.

作者信息

Takahashi H, Cheng K M, Araki T

机构信息

Department of Obstetrics and Gynecology, Nippon Medical School, Tokyo, Japan.

出版信息

Asia Oceania J Obstet Gynaecol. 1993 Jun;19(2):205-12. doi: 10.1111/j.1447-0756.1993.tb00374.x.

Abstract

The effect of antenatal solcoseryl administration on hepatic glycogen synthesis and storage was studied in normal developing and intrauterine growth-retarded (IUGR) rat fetuses using biochemical analyses. The maximal effect of solcoseryl occurred 2 hours after administration. The glycogen content of the liver showed a significant increase in normal and IUGR fetuses with antenatal solcoseryl administration compared to their non-solcoseryl counterparts (p < 0.05). The activities of glycogen synthase enzymes, total and active forms, showed significant increases, at p < 0.05 and p < 0.005, respectively, in IUGR fetuses with antenatal solcoseryl administration. Active synthase also increased in normal fetuses with antenatal solcoseryl administration (p < 0.05). There were no significant changes in the activities of glycogen phosphorylase enzyme. These findings suggest that antenatal solcoseryl administration stimulates hepatic glycogen synthesis and storage in IUGR rat fetuses, and thus might favorably influence the development of neonatal hypoglycemia.

摘要

采用生化分析方法,研究了产前给予索高捷疗对正常发育和宫内生长受限(IUGR)大鼠胎儿肝脏糖原合成与储存的影响。索高捷疗的最大效应出现在给药后2小时。与未给予索高捷疗的胎儿相比,产前给予索高捷疗的正常和IUGR胎儿肝脏糖原含量显著增加(p<0.05)。产前给予索高捷疗的IUGR胎儿中,糖原合酶的总活性形式和活性形式的活性分别显著增加,p值分别<0.05和<0.005。产前给予索高捷疗的正常胎儿中活性合酶也增加(p<0.05)。糖原磷酸化酶的活性没有显著变化。这些发现表明,产前给予索高捷疗可刺激IUGR大鼠胎儿肝脏糖原的合成与储存,从而可能对新生儿低血糖的发展产生有利影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验